Tao, Li <br/><br/>
MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  May 2020 
 - 109962 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2020.109962  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival<br/>DNA-Binding Proteins--genetics<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Nude<br/>MicroRNAs--genetics<br/>Neoplasms, Experimental--drug therapy<br/>Transcription Factors--genetics